Latest Articles

Chelsea Hospital Introduces Augmented Reality for Endometriosis Patients - National Today

Chelsea Hospital Introduces Augmented Reality for Endometriosis Patients National Today

Woman Gets Endometriosis Diagnosis After Years of ‘Debilitating’ Pain, Calls Treatment Options 'Barbaric’ - AOL.com

Woman Gets Endometriosis Diagnosis After Years of ‘Debilitating’ Pain, Calls Treatment Options 'Barbaric’ AOL.com

Gurgaon: Woman with severe endometriosis and 10-cm cysts on ovaries finally becomes a mother after timely treatment - Mid-day

Gurgaon: Woman with severe endometriosis and 10-cm cysts on ovaries finally becomes a mother after timely treatment Mid-day

Alexis Roderick Joel cuts ribbon on LI endometriosis research lab after fighting painful disease - MSN

Alexis Roderick Joel cuts ribbon on LI endometriosis research lab after fighting painful disease MSN

‘I ignored period pain, then my organs got stuck together’: How a 31-year-old teacher beat endometriosis to birth a child - The Indian Express

‘I ignored period pain, then my organs got stuck together’: How a 31-year-old teacher beat endometriosis to birth a child The Indian Express

Not just bad periods: Myths around endometriosis that delay diagnosis - MSN

Not just bad periods: Myths around endometriosis that delay diagnosis MSN

Endometriosis breakthrough: Simple five-minute test could transform treatment - MSN

Endometriosis breakthrough: Simple five-minute test could transform treatment MSN

AR tech prepares patients for endometriosis surgery - AOL.com

AR tech prepares patients for endometriosis surgery AOL.com

Correction to "Bushen Xiaozheng Decoction Improves Immunosuppression in a Rat Model of Endometriosis by Reducing IL-10 and TGF-β Levels".

Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …